Inventor · disambiguated record
Stephen St-Gallay
Also filed as: ST-GALLAY STEPHEN · ST-GALLAY STEPHEN ANTHONY
14 granted patents·5 pending applications·16 citations·filing 2008–2024
86Inventor score
Top patents by PatentIndex Score
19 records- 0191US11981667B2Sulfonamide carboxamide compoundsINFLAZOME LTD·Filed 2022·Granted May 14, 2024·1 cites·8 claims
- 0290US11370776B2Sulfonylureas and sulfonylthioureas as NLRP3 inhibitorsINFLAZOME LTD·Filed 2018·Granted Jun 28, 2022·6 cites·19 claims
- 0383US11465992B2Sulfonamide carboxamide compoundsINFLAZOME LTD·Filed 2018·Granted Oct 11, 2022·1 cites·37 claims
- 0481US11613542B2Sulfonylureas and sulfonylthioureas as NLRP3 inhibitorsINFLAZOME LTD·Filed 2018·Granted Mar 28, 2023·2 cites·32 claims
- 0580US11542255B2Sulfonylureas and sulfonylthioureas as NLRP3 inhibitorsINFLAZOME LTD·Filed 2018·Granted Jan 3, 2023·2 cites·24 claims
- 0680US11518739B2Sulfonamide carboxamide compoundsINFLAZOME LTD·Filed 2018·Granted Dec 6, 2022·2 cites·22 claims
- 0779US11623922B2CompoundsINFLAZOME LTD·Filed 2018·Granted Apr 11, 2023·1 cites·16 claims
- 0879US2025115591A1Novel sulfonamide carboxamide compoundsINFLAZOME LTD·Filed 2024·Application pending·0 cites
- 0976US11926600B2Sulfonylureas and sulfonylthioureas as NLRP3 inhibitorsINFLAZOME LTD·Filed 2018·Granted Mar 12, 2024·1 cites·12 claims
- 1061US8012980B2Isoquinolinone derivativesASTRAZENECA AB·Filed 2009·Granted Sep 6, 2011·0 cites·5 claims
- 1150US12168653B2Sulfonamide derivates as NLRP3 inhibitorsINFLAZOME LTD·Filed 2019·Granted Dec 17, 2024·0 cites·18 claims
- 1250US2023257371A1Cyclic cyanoenone derivatives as modulators of keap1ALTMAN MICHAEL·Filed 2021·Application pending·0 cites
- 1348US2022289766A1Macrocyclic sulfonylurea derivatives useful as nlrp3 inhibitorsINFLAZOME LTD·Filed 2020·Application pending·0 cites
- 1446US11773058B2Sulfonamide carboxamide compoundsINFLAZOME LTD·Filed 2018·Granted Oct 3, 2023·0 cites·20 claims
- 1545US8012979B2Compounds and their uses 707ASTRAZENECA AB·Filed 2008·Granted Sep 6, 2011·0 cites·13 claims
- 1644US12030879B2Sulfonyl acetamides as NLRP3 inhibitorsINFLAZOME LTD·Filed 2019·Granted Jul 9, 2024·0 cites·23 claims
- 1743US12012392B2Sulfonamide carboxamide compoundsINFLAZOME LTD·Filed 2018·Granted Jun 18, 2024·0 cites·20 claims
- 1842US2021122739A1Novel sulfonamide carboxamide compoundsINFLAZOME LTD·Filed 2018·Application pending·0 cites
- 1941US2020361895A1Novel sulfonamide carboxamide compoundsINFLAZOME LTD·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stephen St-Gallay files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →